Screen shot 2014-06-05 at 15.24.31
Cancer52’s briefing paper on Access to Orphan Medicines in the UK today, published 5th June 2014.
Latest News
- NICE publishes draft recommendation for zanidatamab
- Biliary tract cancer patient and caregiver experiences survey 2025 report
- A message from Helen Morement, DSc (hc), AMMF’s CEO
- The Scottish Government approve molecular profiling programme for cholangiocarcinoma patients
- AMMF is Shaping the Future for Cholangiocarcinoma in Westminster
- In Memory of James Hastings
- Ivosidenib approved for reimbursement in Ireland
- Scottish Parliament debates cholangiocarcinoma awareness
- Scottish Parliament to debate cholangiocarcinoma awareness
- Jess’s Rule: New Guidance for GPs in England
- Durvalumab approved for reimbursement in Ireland
- CCA-UK – Annual Meeting
- AMMF unites with cancer charities to urge the government to fully fund the National Cancer Plan
- 10 Year Health Plan for England
- Animals for AMMF - Pets in Purple
- Shaping the new National Cancer Plan
- Addressing shortages of pancreatic enzyme replacement therapy (PERT)
- The Lancet publish an article co-authored by AMMF’s CEO for World CCA Day 2025
- Half of cancer patients not getting the right treatments
- AMMF founder awarded an Honorary Doctorate for services to medicine and science
